Roivant Sciences Ltd

ROIV · NASDAQ

$28.58▼ -3.22%

$0.95 today

Mkt cap $20.56B
P/E 0.0
Day $28.56 – $29.64

Confidence

High conviction

menu_book

The read

Roivant Sciences reports Q1 2026 earnings; EPS actual not yet available, shares down 3.2%

Roivant Sciences Ltd reported Q1 2026 earnings with EPS actuals not yet disclosed; shares declined 3.2% to $28.58. Analysts maintain a buy consensus with a $36.53 target price, reflecting 36.6% upside. Institutional ownership remains high at 73%, while growth metrics show mixed signals with strong next-year EPS growth forecasted at 21.8%.

Confidence note: Analysis based on incomplete EPS data but supported by strong analyst consensus, institutional ownership, and clear forward growth estimates.

fact_check

What happened

receipt_long

Earnings print

Actual EPS for Q1 2026 is not yet available; consensus estimate was -$0.38.

signpost

Guidance

No explicit guidance update reported; analyst consensus remains buy with a target price of $36.53, implying 36.6% upside from current price.

candlestick_chart

Price reaction

Shares declined 3.2% on the day of the earnings report, closing at $28.58 from $29.53 prior close.

newspaper

Street narrative

Despite lack of reported EPS, the stock traded lower post-earnings; analyst consensus remains positive with strong institutional backing and expected EPS growth next year of 21.8%.

lightbulb

So what

swap_horiz

What changed

EPS actuals remain undisclosed; shares fell 3.2% post-earnings to $28.58 from $29.53.

sell

What the market is pricing

Market is pricing in uncertainty due to missing EPS data, reflected in a 3.2% share price decline.

insights

Fundamental takeaway

Maintain a cautious buy stance; monitor upcoming EPS actuals and next-quarter guidance for confirmation.

alt_route

Next 30–90 days

trending_upBull

39%

EPS actuals and next-quarter guidance exceed estimates, validating strong growth thesis and analyst targets.

boltReported EPS beats -0.38 estimate
boltNext-quarter guidance confirms or raises growth expectations

balanceBase

36%

EPS actuals align with estimates and guidance remains stable, supporting current valuation and buy consensus.

boltEPS reported near -0.38 estimate
boltGuidance remains unchanged

trending_downBear

25%

EPS misses and/or guidance cut trigger further share price declines and analyst downgrades.

boltEPS misses estimate by wide margin
boltGuidance lowered or growth outlook reduced

checklist

What to do

account_balance_wallet

If you hold it

Hold shares unless EPS actuals miss estimates by more than 10% or guidance is cut materially.

visibility

If you're watching

Consider entry if EPS actuals meet or beat estimates and guidance is stable; avoid if EPS is missing or guidance is lowered.

radar

Keep on your radar

EPS actual release date and reported value
Next-quarter guidance announcement and details
Analyst rating changes and target price revisions
Institutional ownership changes over next 90 days